Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Daxor Corporation

Daxor Corporation (DXR) Stock Overview

Explore Daxor Corporation’s financial performance, market position, analyst ratings, and future outlook.

DXR●NASDAQ
HealthcareMedical - Instruments & Supplies
$10.45
$0.26(2.38%)
U.S. Market opens in 14h 27m

Daxor Corporation (DXR)

Meyka AI Score

Z

Key Financials

Market Cap52.7M
P/E Ratio5.76
EPS (TTM)$0.38
ROE0.22%
Fundamental Analysis

AI Price Forecasts

1 Month$11.77
3 Months$11.49
1 Year Target$12.69

DXR Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Daxor Corporation (NASDAQ: DXR) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Daxor Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of DXR on the NASDAQ shows an RSI of 56.76, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $12.69 for the NASDAQ listing.

Key metrics behind Daxor Corporation's NASDAQ-traded stock include a P/E ratio of 5.76 and a market capitalization of 52.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of DXR on the NASDAQ.

Price Performance (NASDAQ: DXR)

1-Day Change
-2.38%
5-Day Change
-5.09%
1-Month Change
-0.48%
3-Month Change
1.95%
6-Month Change
-17.00%
Year-to-Date (YTD) Change
-29.15%
1-Year Change
4.50%
3-Year Change
5.93%
5-Year Change
8.30%
All-Time (Max) Change
10.00%

Contact Information

https://www.daxor.com
12123308500
109 Meco Lane, Oak Ridge, TN, 37830

Company Facts

370 Employees
IPO DateJul 25, 1983
CountryUS
Actively Trading

Frequently Asked Questions